痴呆症护理研究和心理社会因素
Alana Vanessa Kerr1, Jacqueline Dossetor1, Jody Huynh1
1Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
患有痴呆症的澳大利亚成年人和他们的护理人员对治疗痴呆症症状的医用大麻临床试验非常感兴趣. 这表明越来越多的人支持大麻衍生疗法来改善生活质量.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 老年学是一门学科.
背景情况:
- 痴呆症包括各种大脑疾病,如阿尔茨海默氏症,呈现各种症状,包括情绪变化,焦虑和睡眠障碍.
- 痴呆症的神经精神症状越来越令人担忧,引发了人们对大麻衍生药物的兴趣.
- 现有的研究探索了大麻素在痴呆症患者的症状缓解方面的潜力.
研究的目的:
- 检查澳大利亚成年人对使用大麻素治疗痴呆症症状的态度.
- 评估痴呆症患者,他们的护理人员和健康对照对参与医用大麻临床试验的兴趣.
- 了解有关使用大麻治疗痴呆症的益处和风险的看法.
主要方法:
- 从悉尼大学的FRONTIER研究数据库中向痴呆症患者,研究伙伴 (护理人员) 和健康对照进行了在线问卷调查.
- 该调查评估了人们对药用大麻的态度,感知到的益处和风险,以前的大麻使用经验,以及加入假设临床试验的意愿.
- 总共有77名受访者填写了问卷:22名痴呆症患者,30名研究伙伴和25名健康对照.
主要成果:
- 接受调查的痴呆症患者中有73%表示愿意参加医用大麻临床试验.
- 80%的参与者表示有兴趣参加一个假设的临床试验,研究大麻治疗痴呆症症状.
- 尽管只有24%的人报告以前使用大麻,但人们对通过临床试验探索大麻素的益处有很大的普遍兴趣.
结论:
- 澳大利亚痴呆症患者和护理人员对参与医学大麻疗效临床试验非常感兴趣.
- 这些发现与其他研究一致,表明大麻衍生产品作为潜在的医疗治疗越来越受欢迎.
- 精心设计的临床试验对于扩大痴呆症患者的症状治疗选择至关重要.
更多相关视频
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
4.3K
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
14.1K
相关概念视频
Dementia
482
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
482
Psychological and Sociocultural Causes of Schizophrenia
438
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
438
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
Cognitive Development During Adulthood
740
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
740
Documentation in Long-Term and Home Healthcare Setting
1.4K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.4K
